Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Romiplostim N01”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Looking for participantsNCT07321626
What this trial is testing

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Who this might be right for
Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Delayed Platelet Engraftment+1 more
First Affiliated Hospital of Zhejiang University 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345000
What this trial is testing

Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Treatment-naïve Severe Aplastic Anemia
Qilu Pharmaceutical Co., Ltd. 210
Testing effectiveness (Phase 2)Looking for participantsNCT06992128
What this trial is testing

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 129
Not applicableNot Yet RecruitingNCT07162519
What this trial is testing

Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients

Who this might be right for
Cytotoxic DrugsRomiplostim N01Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 68
Testing effectiveness (Phase 2)Looking for participantsNCT06693791
What this trial is testing

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

Who this might be right for
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 34
Large-scale testing (Phase 3)Not Yet RecruitingNCT06759636
What this trial is testing

FRIENDS-01：A Multicenter Open-label Randomized Controlled Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Who this might be right for
CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University 88
Not applicableLooking for participantsNCT07206823
What this trial is testing

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

Who this might be right for
Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Looking for participantsNCT06613880
What this trial is testing

Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

Who this might be right for
Aplastic AnemiaTPO Receptor Agonists
Institute of Hematology & Blood Diseases Hospital, China 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06898983
What this trial is testing

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Who this might be right for
Cancer Treatment-induced Thrombocytopenia (CTIT)
Anhui Provincial Hospital 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128576
What this trial is testing

Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Zhujiang Hospital 60
Not applicableNot Yet RecruitingNCT07214025
What this trial is testing

Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children

Who this might be right for
Romiplostim N01ITP
Assiut University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07063225
What this trial is testing

Romiplostim N01 for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaRomiplostim N01
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableNot Yet RecruitingNCT07185893
What this trial is testing

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

Who this might be right for
Solid Tumor Malignancies, CancerCTIT-Chemotherapy Induced ThrombocytopeniaThrombocytopenia
Jun wang 106
Large-scale testing (Phase 3)Not Yet RecruitingNCT06440824
What this trial is testing

Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin

Who this might be right for
CTIT-Chemotherapy Induced Thrombocytopenia
Shandong University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06658834
What this trial is testing

Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 129
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400250
What this trial is testing

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Peking Union Medical College Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36